New Treatment for Keratoconus: Corneal Collagen Cross-linking Shows Promise

Keratoconus is a progressive eye disease that affects the cornea, causing it to thin and bulge into a cone shape over time. This condition can lead to visual impairment or even blindness, making it important to find new treatment options to halt or reverse its progression. One such treatment that has shown promise is corneal collagen cross-linking.

Corneal collagen cross-linking involves the use of ultraviolet light and a photosensitizing agent to strengthen the cornea’s collagen fibers. This process helps to stabilize the cornea and prevent further thinning and bulging. Studies have shown that patients who undergo this treatment experience improved vision and a halt in the progression of keratoconus.

Dr. Dolan, of 2020 Vision in Rochester Hills MI, is a leading expert in the field of corneal collagen cross-linking. He has helped many patients with keratoconus by providing this innovative treatment option. Dr. Dolan and his team use the latest technology and techniques to ensure the best possible results for their patients.

If you or someone you know is experiencing visual impairment or has been diagnosed with keratoconus, it’s important to seek treatment from a qualified specialist. With the help of corneal collagen cross-linking, patients with keratoconus can look forward to improved vision and a brighter future.

To schedule a consultation with Dr. Dolan and the team at 2020 Vision in Rochester Hills MI, please call 248-375-0040 today. Don’t let keratoconus hold you back from living the life you deserve. Contact us and take the first step toward clear vision and a better tomorrow.